Adjuvant chemotherapy harms QOL in breast cancer

By  

Inpharma, Vol. 1, Iss. 1417, 2003-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Effect of Creatinine Clearance on Patterns of Toxicity in Older Patients Receiving Adjuvant Chemotherapy for Breast Cancer

By Hurria Arti   Hurria Anju   Brogan Kelly   Panageas Katherine S.   Pearce Carol   Norton Larry   Jakubowski Ann   Howard Jane   Hudis Clifford  

Drugs & Aging, Vol. 22, Iss. 9, 2005-01 ,pp. : 785-791

Adis International

Access to resources Recommend Favorite

Change in Cycle 1 to Cycle 2 Haematological Counts Predicts Toxicity in Older Patients with Breast Cancer Receiving Adjuvant Chemotherapy

By Hurria Arti   Brogan Kelly   Panageas Katherine S.   Jakubowski Ann   Zauderer Marjorie   Pearce Carol   Norton Larry   Howard Jane   Hudis Clifford  

Drugs & Aging, Vol. 22, Iss. 8, 2005-01 ,pp. : 709-715

Adis International

Access to resources Recommend Favorite

Docetaxel as adjuvant and neoadjuvant treatment for patients with breast cancer

By Heys Steven D   Sarkar Tarun   Hutcheon Andrew W  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 10, 2004-10 ,pp. : 2147-2157

Informa Healthcare

Access to resources Recommend Favorite

Granulocyte-Colony Stimulating Factor Use and Medical Costs after Initial Adjuvant Chemotherapy in Older Patients with Early-Stage Breast Cancer

By Griffiths Robert I.   Barron Richard L.  

PharmacoEconomics, Vol. 30, Iss. 2, 2012-02 ,pp. : 103-118

Adis International

Access to resources Recommend Favorite